<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-07-16 10:55:26Amyotrophic lateral sclerosis Agency for Toxic Substances and Disease Registry Riluzole Neuroscience ALS Society of Canada Rare diseases Health Motor neurone disease |
| Masitinib for amyotrophic lateral sclerosis – add-on therapy to riluzoleDocID: 1gqBs - View Document |
| Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzoleDocID: 17z0L - View Document |
| Dear (Name of your Congressional and Senatorial Official at the Federal Level), I am writing to express interest in the approval status of a bio-drug produced by Genervon Biopharmaceuticals LLS, known as GM604 or GM6DocID: 173Yp - View Document |
| Executive Summary: Towards Improving Outcomes for Patients with ALSDocID: 14ZbG - View Document |
| AMYOTROPHIC LATERAL SCLEROSIS (ALS) (also known as Lou Gehrig’s Disease) DISEASE FACT SHEET AND OPPORTUNITY FOR TIRASEMTIV What is ALS? About Us Cytokinetics is a clinical-stage biopharmaceutical companyDocID: 13OuA - View Document |